The expression of MAPK, NF-κB, and AGER1 in the liver was significantly lower in the DL-arginine-treated STZ-induced T2DM rats than in the STZ-induced T2DM rats (p < 0.05) (Figure 12A). Here, NFKB1 is linked to type 2 diabetes mellitus.